Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
10/19/2006 | US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2) |
10/19/2006 | US20060234239 An oligonucleotide targeted to (hybridizing with) a nucleic acid molecule encoding human insulin like growth factor I receptor; treatment of proliferative and inflammatory skin disorders and cancer |
10/19/2006 | US20060233811 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
10/19/2006 | US20060233804 IGF antagonist peptides |
10/19/2006 | US20060233796 Method of modulating memory effector T-cells and compositions |
10/19/2006 | US20060233783 Topical composition in the form of a gel for treating skin burns |
10/19/2006 | US20060233738 Composition for promoting production of type 1 collagen and/or elastin |
10/19/2006 | US20060233737 Composition comprising an extract of aphanizomenon flos-aquae, use thereof and preparation of same |
10/19/2006 | US20060233735 Psoriasis; applying daily to hair an aqueous mixture of clobetasol propionate, an anionic surfactant, an amphoteric surfactant, and ethanol; leaving it for 2.5 to 15 minutes, and rinsing with water. |
10/19/2006 | US20060233729 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
10/19/2006 | US20060233727 Film foaming hydroalcoholic foam |
10/19/2006 | US20060233714 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions |
10/19/2006 | DE102005021382A1 Agent, useful to treat and prevent skin diseases e.g. psoriasis, preferably psoriasis of the palms and foot, nail psoriasis, neurodermatitis and atopic dermatitis, comprises zeolite, stinging nettle extract and further materials |
10/19/2006 | CA2604028A1 Novel use of zinc gluconate for treating hydradenitis suppurativa |
10/19/2006 | CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
10/19/2006 | CA2602968A1 Crystals of morphinan derivative and process for producing the same |
10/18/2006 | EP1712239A2 Interleukin-1 inhibitors in the treatment of diseases |
10/18/2006 | EP1712236A2 Methods of treating acne |
10/18/2006 | EP1711210A2 Combined use of prame inhibitors and hdac inhibitors |
10/18/2006 | EP1711194A1 A plant extract and its pharmaceutical and cosmetic use |
10/18/2006 | EP1711190A1 Agent for treating inflammatory diseases |
10/18/2006 | EP1711177A1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS |
10/18/2006 | EP1572683B1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
10/18/2006 | EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
10/18/2006 | EP1283828B1 Novel polymorph v of torasemide |
10/18/2006 | EP1239850B1 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents |
10/18/2006 | EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
10/18/2006 | EP1107957B1 Pyrimidine compounds |
10/18/2006 | CN1849400A Polynucleotides and polypeptides of the erythropoietin gene |
10/18/2006 | CN1849135A Methods for treating interleukin-6-related diseases |
10/18/2006 | CN1849125A Therapeutic agent for ageing macular degeneration |
10/18/2006 | CN1847263A Protein from snake venom for preventing and treating pyemia |
10/18/2006 | CN1847262A One kind of protein and its use |
10/18/2006 | CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists |
10/18/2006 | CN1847229A Novel compounds |
10/18/2006 | CN1846774A Specific Chinese medicine health tea with functions of beautifying and moistening skin |
10/18/2006 | CN1846771A Spot-eliminating and physique strengthening composition |
10/18/2006 | CN1846769A Production process and usage of skin care Chinese medicine capsule |
10/18/2006 | CN1846754A Externally applied Chinese herbal medicine prepn for treating burns and scalds |
10/18/2006 | CN1846745A Prepn process of psoriasis treating ointment |
10/18/2006 | CN1846738A Medicine composition and its prepn process and quality control method |
10/18/2006 | CN1846733A Externally applied skin care liquid extracted from plant and its prepn process |
10/18/2006 | CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
10/18/2006 | CN1846713A Snake venom extract for preventing and treating pyemia |
10/18/2006 | CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
10/18/2006 | CN1279975C Inducer of blood vessel neogenesis |
10/18/2006 | CN1279968C Chinese medicine for treating white hair and its preparing method |
10/18/2006 | CN1279966C Danduqing granular and its preparation method |
10/18/2006 | CN1279952C Medicine for treating burns and scalds |
10/18/2006 | CN1279946C Medicinal wine and its producing method |
10/18/2006 | CN1279940C Antiseptic and pest killing skin cleaning agent and preparing method |
10/18/2006 | CN1279937C Antiseptic and insect killing washing liquid and preparing method |
10/18/2006 | CN1279926C Medicine for treating burns and scalds and its preparation method |
10/18/2006 | CN1279917C Vulnerary, its preparation method and process of using |
10/18/2006 | CN1279914C Minoxidil-containing preparations |
10/18/2006 | CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
10/18/2006 | CN1279901C Pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one |
10/18/2006 | CN1279894C Preparations for coating wound |
10/17/2006 | US7122679 Multicyclic compounds and the use thereof |
10/17/2006 | US7122677 NK1 antagonists |
10/17/2006 | US7122669 Purine derivatives, preparation method and pharmaceutical compositions containing same |
10/17/2006 | US7122665 Heterocyclic compounds |
10/17/2006 | US7122639 Chemokine alpha-2 antibodies |
10/17/2006 | US7122635 Method and composition for angiogenesis inhibition |
10/17/2006 | US7122556 Phenylalanine enamide derivatives |
10/17/2006 | US7122551 Metalloproteinase inhibitor compounds |
10/17/2006 | US7122550 Protein kinase inhibitors |
10/17/2006 | US7122547 Anthranilic acid amides and the use thereof as medicaments |
10/17/2006 | US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
10/17/2006 | US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases |
10/17/2006 | US7122530 24-hydroxyvitamin D, analogs and uses thereof |
10/17/2006 | US7122524 Stimulating nerve growth, administering glycyl-L-phenylalanyl-L-prolineamide, N,N-diethyl-isoleucyl-phenylalanyl-L-proline ethylamide, N,N-diethyl-isoleucyl-isoleucyl-prolineamide; due to ischemic, traumatic or toxic origin |
10/17/2006 | US7122517 Crystallized structure of type IV collagen NC1 domain hexamer |
10/17/2006 | US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled |
10/17/2006 | US7122336 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
10/17/2006 | US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody |
10/17/2006 | US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
10/17/2006 | CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
10/17/2006 | CA2352964C A method for enhancing protective cellular responses to genotoxic stress in skin |
10/17/2006 | CA2322502C Protease inhibitors in absorbent articles |
10/17/2006 | CA2212888C A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds |
10/17/2006 | CA2177179C Antagonists to chaperonin 10 |
10/17/2006 | CA2148988C Filamentous bacteria extracts used as cosmetic agents against the ageing of skin |
10/12/2006 | WO2006107184A1 A pharmaceutical composition for the treatment of atopic dermatitis containing 4-hydroxy-5-methoxy-4-[2-methyl-3-(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro [2,5]octan-6-one |
10/12/2006 | WO2006106914A1 Novel cyclic compound having pyrimidinylalkylthio group |
10/12/2006 | WO2006106727A1 Benzyloxypropylamine derivative |
10/12/2006 | WO2006106633A1 Uv-induced dermatitis inhibitor and atopic dermatitis inhibitor |
10/12/2006 | WO2006106528A1 Novel peptides useful for treatment of alopecia |
10/12/2006 | WO2006106398A1 Method for improving sensory characteristics of semisolid predominantly anhydrous lipids |
10/12/2006 | WO2006106220A2 Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals. |
10/12/2006 | WO2006106164A1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles |
10/12/2006 | WO2006105811A1 Compounds useful as modulators of the proteasome activity |
10/12/2006 | WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response |
10/12/2006 | WO2006063865A3 Compositions for enhancing keratinocyte migration and epidermal repair via a receptor containing osmrbeta as a subunit, and applications thereof |
10/12/2006 | WO2006047516A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
10/12/2006 | WO2006040688A3 Inhibitors of acetylcholinesterase for treating skin diseases |
10/12/2006 | US20060229706 Drug-Delivery Endovascular Stent and Method for Treating Restenosis |
10/12/2006 | US20060229346 Method for treating vascular hyperpermeable disease |
10/12/2006 | US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
10/12/2006 | US20060229316 Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them |